Clin2
NCT05629845Possibly a fitRecruiting

Prevent repeat stomach bleeding using an ultrasound-guided scope

Hepatocellular CarcinomaVariceal Bleeding

Part of Cancer, Digestive system clinical trials.

This study compares two ways to stop variceal bleeding (bleeding from swollen veins in the esophagus or stomach) from coming back in people with liver cancer. It tests whether an ultrasound-guided technique during endoscopy can reduce repeat bleeding compared with standard endoscopy methods.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
84 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older and have hepatocellular carcinoma (liver cancer).
  • You had bleeding from swollen esophagus/stomach veins within the last 4 weeks that was successfully controlled by standard endoscopy.
  • If your bleeding was from esophageal veins, the usual treatment was banding; if from stomach veins, it was glue injection.
  • You can sign consent in writing and agree to follow study procedures.
  • Your bleeding must be from varices (swollen veins), not another source in the gut.
  • You do not have serious bleeding-safety problems that don’t improve with transfusions (high INR over 1.5 or very low platelets under 50,000).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06819566Recruiting· Phase 2
Preventing bleeding from enlarged veins in the esophagus

This study tests whether tying off high-risk veins in the esophagus before starting a common liver cancer treatment can prevent bleeding. It is for people with liver cancer that has spread but who have never had cancer treatment before.

Seoul, Song-pa
NCT07571876Not yet recruiting
Ultrasound to Predict Esophageal Bleeding Risk in Liver Disease

This study tests whether ultrasound imaging can predict which patients with cirrhosis (scarring of the liver) are at higher risk of dangerous bleeding from enlarged veins in the esophagus. If successful, this could help doctors decide which patients need preventive treatment.

NCT06836778Not yet recruiting
Pill alone vs. pill plus banding to prevent variceal bleeding in liver cancer

This trial compares two approaches to prevent first-time bleeding from enlarged veins in the food pipe (varices) in people with liver cancer and cirrhosis. One group receives a daily pill (carvedilol), and the other receives the pill plus a procedure (endoscopic banding) to tie off the veins.

New Delhi, National Capital Territory of Delhi
NCT07532915Recruiting
Two endoscopy methods to prevent stomach vein bleeding

This trial compares two endoscopic (camera-guided) procedures to prevent or treat bleeding from enlarged veins in the stomach. Both approaches aim to stop dangerous bleeding or prevent it from happening in high-risk patients.

Guangzhou, Guangdong
NCT06970509Recruiting
Improving treatment for stomach bleeding from liver disease

This trial studies better ways to use endoscopy and other treatments to stop bleeding in the stomach or esophagus caused by high blood pressure in the liver (portal hypertension). It may help if you have been diagnosed with portal hypertension and have varices (enlarged veins) in your esophagus or stomach.

Guangzhou, Guangdong
NCT05597488Recruiting
Measuring pressure to predict varice treatment response

This study checks whether a special ultrasound-guided measurement of blood pressure in your liver can help predict how well endoscopic treatment (banding varices or injecting bleeding sites) will work. It aims to improve outcomes by identifying who is more likely to respond.

Hong Kong, Hong Kong

Hear when a new Hepatocellular Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.